University of Oxford, Department of Zoology, Oxford, United Kingdom.
Clinical Science Institute, National University of Ireland, Galway, Republic of Ireland.
Euro Surveill. 2018 May;23(20). doi: 10.2807/1560-7917.ES.2018.23.20.17-00474.
Invasive meningococcal disease surveillance in Europe combines isolate characterisation and epidemiological data to support public health intervention. A representative European Meningococcal Strain Collection (EMSC) of IMD isolates was obtained, and whole genome sequenced to characterise 799 EMSC isolates from the epidemiological year July 2011-June 2012. To establish a genome library (GL), the isolate information was deposited in the pubMLST.org/neisseria database. Genomes were curated and annotated at 2,429 meningococcal loci, including those defining clonal complex, capsule, antigens, and antimicrobial resistance. Most genomes contained genes encoding B (n = 525; 65.7%) or C (n = 163; 20.4%) capsules; isolates were genetically highly diverse, with >20 genomic lineages, five of which comprising 60.7% (n = 485) of isolates. There were >350 antigenic fine-types: 307 were present once, the most frequent (P1.7-2,4:F5-1) comprised 8% (n = 64) of isolates. Each genome was characterised for Bexsero Antigen Sequence Typing (BAST): 25.5% (n = 204) of isolates contained alleles encoding the fHbp and/or the PorA VR1 vaccine component, but most genomes (n = 513; 64.2%) did not contain the NadA component. EMSC-GL will support an integrated surveillance of disease-associated genotypes in Europe, enabling the monitoring of hyperinvasive lineages, outbreak identification, and supporting vaccine programme implementation.
在欧洲,侵袭性脑膜炎球菌病监测结合了分离株特征和流行病学数据,以支持公共卫生干预。获得了具有代表性的欧洲脑膜炎球菌菌株收集(EMSC)的 IMD 分离株,并对其进行了全基因组测序,以对 2011 年 7 月至 2012 年 6 月的流行病学年度的 799 个 EMSC 分离株进行特征描述。为了建立基因组文库(GL),将分离株信息存入 pubMLST.org/neisseria 数据库。对 2429 个脑膜炎球菌基因座的基因组进行了编辑和注释,包括定义克隆复合体、荚膜、抗原和抗微生物药物耐药性的基因座。大多数基因组包含编码 B(n=525;65.7%)或 C(n=163;20.4%)荚膜的基因;分离株在遗传上高度多样化,有>20 个基因组谱系,其中 5 个谱系包含 60.7%(n=485)的分离株。有>350 个抗原精细型:307 个为单次出现,最常见的(P1.7-2,4:F5-1)占分离株的 8%(n=64)。对每个基因组进行 Bexsero 抗原序列分型(BAST)的特征描述:25.5%(n=204)的分离株包含编码 fHbp 和/或 PorA VR1 疫苗成分的等位基因,但大多数基因组(n=513;64.2%)不包含 NadA 成分。EMSC-GL 将支持欧洲疾病相关基因型的综合监测,能够监测高侵袭性谱系、识别暴发,并支持疫苗接种计划的实施。